Tag: Cancer: Breast
SABCS: Outcomes No Worse for Survivors With Less Frequent Mammograms
Breast cancer-specific survival at five years noninferior with less frequent mammograms versus annual mammograms
SABCS: Positive Outcomes Seen When Pausing Endocrine Therapy to Become Pregnant
Incidence of breast cancer-free interval events similar for those undergoing ovarian stimulation for cryopreservation or not
SABCS: Neoadjuvant Chemo Can Let Breast Cancer Patients Skip Nodal RT
Skipping adjuvant regional nodal irradiation does not increase risk for recurrence or death after neoadjuvant chemo before breast-conserving surgery
SABCS: Younger Postmenopausal Breast Cancer Patients Can Avoid Adjuvant RT
Very low risk for recurrence seen for postmenopausal women aged 50 to 69 years who did not receive radiotherapy after breast-conserving surgery
Prediction Model for Invasive Breast Cancer Improved With Additional Risk Factors
Body mass index was associated with largest improvement in estimated risk for individual women
ASTRO Issues Guidance Related to Partial Breast Irradiation
Daily or every-other-day external beam PBI regimen preferred over twice-daily regimen due to late toxicity concerns
Neratinib, Fulvestrant, Trastuzumab Combo Aids Metastatic Breast Cancer
Three-drug combination beneficial for HR-positive HER2-mutant metastatic breast cancer with prior CDK4/6i therapy
Mortality Higher for Black Patients Receiving Neoadjuvant Chemo for Breast Cancer
Black patients have increased mortality in refractory, sensitive disease; Asians have lower risk in refractory, sensitive, very sensitive disease
Overall Survival Benefit Up for Pyrotinib + Capecitabine in HER2-Positive Breast Cancer
Overall survival benefit demonstrated among patients with metastatic breast cancer who had received trastuzumab and taxanes
Risk for Breast Cancer Examined After False-Positive Mammogram
Higher hazard ratios seen for women aged 60 to 75 years at examination, with lower mammographic breast density
